drugset

drugset / Trial / NCT04945226

A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

NCT04945226 ↗

Phase 1/2 Completed 40 enrolled Inventage Lab., Inc.

RandomizedSequentialOpen-labelTreatment

Summary

A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

Timeline

Start: 2021-09-21
Primary completion: 2022-02-08
Completion: 2022-02-08

Publications

Kim H, Ryu C, Lee M, Lee KR, Kim J. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia. Adv Ther. 2024 Jul;41(7):2936-2952. doi: 10.1007/s12325-024-02890-1. Epub 2024 Jun 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Finasteride	Small molecule	1 mg	Oral
Subject	IVL3001	Unknown	—	Subcutaneous

Indications